Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07624500 · ClinicalTrials.gov registry record · NA
Food and Metabolism Study
A NA study, sponsored by Clinical Nutrition Research Center, Illinois Institute of Technology.
- Recruiting
- Registry status
- NA
- Development phase
- 82
- Enrollment target
NCT07624500: Recruiting NA study, sponsored by Clinical Nutrition Research Center, Illinois Institute of Technology.
NCT07624500 is a NA study that is actively recruiting participants, run by Clinical Nutrition Research Center, Illinois Institute of Technology. The registered enrollment target is 82 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07624500, a NA study, is actively recruiting participants, sponsored by Clinical Nutrition Research Center, Illinois Institute of Technology.
- RECRUITING
- Registry status
- NA
- Development phase
- 82 participants
- Enrollment target
Study Summary
In this study, Investigators are interested in looking at the influence of eating avocados regularly, which are rich in healthy fats, fibers, and unique carbohydrates, on triglyceride and glucose metabolism in people with prediabetes and insulin resistance.
Primary Outcome
analyzed by McLendon labs
Interventions
- OTHER Avocado meal plan
- OTHER Control meal plan
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 82 participants |
| Start Date | 2026-06-03 |
| Est. Completion | 2027-12-31 |
| Phase | NA |
What NCT07624500 shows while recruiting
NCT07624500 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 82 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).
The record links to 0 conditions, and to 2 interventions - of which Avocado meal plan is the first listed.
NCT07624500 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07624500 about?
NCT07624500 is a clinical study titled "Food and Metabolism Study". In this study, Investigators are interested in looking at the influence of eating avocados regularly, which are rich in healthy fats, fibers, and unique carbohydrates, on triglyceride and glucose metabolism in people with prediabetes and insulin resistance.
What is the current status of trial NCT07624500?
This trial is currently recruiting. It is a NA study. The enrollment target is 82 participants. The study started on 2026-06-03. Estimated completion is 2027-12-31.
What interventions are being tested in trial NCT07624500?
The interventions under investigation include: Avocado meal plan (OTHER), Control meal plan (OTHER).
Who is sponsoring clinical trial NCT07624500?
This trial is sponsored by Clinical Nutrition Research Center, Illinois Institute of Technology, which has 59 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07624500's enrollment target sits among peer trials
82 990th of 2000 higher than 1,009 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03319901 · 82 participants · Phase 1
Venetoclax and Chemotherapy as Frontline Therapy in Older Patients and Patients With Relapsed/Refractory ALL
- NCT03493425 · 82 participants · Phase 2
Chemotherapy Before Surgery and Radiation Therapy or Surgery and Radiation Therapy Alone in Treating Patients With Nasal and Paranasal Sinus Cancer That Can Be Removed by Surgery
- NCT04105270 · 82 participants · Phase 2
RMT in Combination With Durvalumab + Chemo in Untreated Adenocarcinoma NSCLC. A Randomized Double Blind Phase II Trial
- NCT04428658 · 82 participants · NA
Randomized Trial of Supplemental Synchronous and Asynchronous Telehealth to Improve Glycemic Control for Pediatric Patients With Type 1 Diabetes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI